In reply to
Dan Goodman
@neuralreckoning@neuromatch.social
I'm a computational neuroscientist and science reformer. I'm based at Imperial College London. I like to build things and organisations, including the Brian spiking neural network simulator, Neuromatch and the SNUFA spiking neural network community.
neuromatch.social
Dan Goodman
@neuralreckoning@neuromatch.social
I'm a computational neuroscientist and science reformer. I'm based at Imperial College London. I like to build things and organisations, including the Brian spiking neural network simulator, Neuromatch and the SNUFA spiking neural network community.
neuromatch.social
@neuralreckoning@neuromatch.social
·
Nov 28, 2025
@adredish @elduvelle @albertcardona @jonmsterling the only difference I see is in eLife's favour. I know for a fact that there are papers out there published in good journals where there was only one reviewer and that reviewer stated that the paper has misleading claims not justified by the results. I know because I was that reviewer. And it didn't happen only once. So the fact that there is one paper in eLife where the reviewers weren't keen doesn't seem like a very high proportion to me, and there is the huge advantage that we can actually see it. In the cases I know about I'm the only person who knows this. But those papers are being listed on CVs. What we need to do is not to consider eLife papers as a downgrade compared to a "refereed" one, but get over the deeply wrong idea that having gone through an opaque peer review process counts for much.
View full thread on neuromatch.social
7
2
6
Conversation (2)
Showing 0 of 2 cached locally.
Syncing comments from the remote thread. 2 more replies are still loading.
Loading comments...